LASER and Radiofrequency and Genitourinary Syndrome of Menopause (EPMLARF-arm1)
Postmenopausal Atrophic Vaginitis, Postmenopausal Symptoms, Genitourinary Symptoms
About this trial
This is an interventional treatment trial for Postmenopausal Atrophic Vaginitis focused on measuring postmenopause, atrophic vaginitis, vulvovaginal atrophy, treatment, LASER, Radiofrequency, estriol, strogen therapy
Eligibility Criteria
Inclusion Criteria:
- Women between 2 and 5 years after menopause, without hormone therapy for at least 2 years
To present, at least moderate, or severe intensity (score 4 or more of visual analog scale ( 0-10)) of one of the signs or symptoms of of vulvovaginal atrophy:
- Burning
- Discomfort
- Dryness
- Cracks
- Pruritus
- Lack of vaginal lubrication
- Penetration dyspareunia that began at the menopausal or postmenopausal transition
- Decreased vaginal epithelium turgor and trophism
- Deletion of mucous and skin folds.
The Exclusion criteria will be:
- Active genital infection, active infection of HPV (human papillomavirus) or Herpes, users of medications with estrogenic effect (digoxin, tamoxifen and other chemicals)
- Postmenopausal genital bleeding, uncontrolled diabetes, use of multivitamins with zinc, use of copper or hormonal IUDs (intrauterine device) at the time of inclusion, presence of genitourinary or rectovaginal fistulas.
Sites / Locations
- Federal University of Sao Paulo - Unifesp
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
LASER
Micro Ablative Radiofrequency
Estriol
The patients will receive 3 consecutive applications of intravaginal and vulvar CO2 (carbon dioxide)LASER, according to the manufacturer protocol for vaginal atrophy. The applications will be separated by the interval of 30 days
The patients will receive 3 consecutive applications of intravaginal and vulvar MIcro ablative radiofrequency, according to the manufacturer protocol for vaginal atrophy. The applications will be separated by the interval of 30 days
The patient will use intravaginal estriol, daily for 2 weeks and them twice a week for 3 months . Each 30 days, the patients will have an appointment when will be checked the weight of the estriol tube to verify the correct use.